Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix, Inc. to Host Earnings Call

Accesswire April 19, 2018

NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting

GlobeNewswire April 18, 2018

NeuroMetrix, Inc. Announces Date for 2018 First Quarter Financial Results Conference Call

GlobeNewswire April 11, 2018

NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief

GlobeNewswire April 10, 2018

NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017

Business Wire September 5, 2017

Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference

Business Wire August 31, 2017

NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain

Business Wire August 29, 2017

NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep

Business Wire August 15, 2017

NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan

Business Wire August 3, 2017

NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015

Business Wire July 27, 2017

NeuroMetrix Reports Q2 2017 Financial Results

Business Wire July 20, 2017

Investor Network: NeuroMetrix, Inc. to Host Earnings Call

Accesswire July 20, 2017

NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call

Business Wire July 13, 2017

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

Business Wire July 10, 2017

NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics

Business Wire July 6, 2017

NeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist

Business Wire June 26, 2017

NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program

Business Wire June 23, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  June 13, 2017

Mid-Day Market Update: Cavco Rises After Q4 Results; CEL-SCI Shares Plunge

Benzinga.com  June 13, 2017

Mid-Morning Market Update: Markets Open Higher; John Wiley Reports Strong Q4 Results

Benzinga.com  June 13, 2017